On BBC Reporting Scotland, a trade union leader is once more allowed to present his own narrow views as somehow representative of a profession he has not consulted and of other health professions who have not expressed any view at all.
BBC regular Lewis Morrison, above, is always available to find fault with anything the Scottish Government does. The decision to delay the second dose to maximise the vaccination rate is supported by all leading professionals but a jumped-up shop steward is platformed, unchallenged, by BBC Scotland:
Doctors raise concerns that delaying the second dose of the Pfizer vaccine could risk wasting existing supplied. Doctors in Scotland have raised concerns about changes to the first phase of the Covid vaccination plan. The UK will give both parts of the Oxford and Pfizer vaccines 12 weeks apart having initially planned to leave 21 days between the Pfizer jags. Today the BMA have raised concerns about that because they could have people left without typical doses. That will damage the confidence and staff who were expecting that second dose.
No doctors other than Morrison are quoted. No scientific survey of opinion has been undertaken. As in other professions offering job satisfaction, few want a role in the union and so people like Morrison are the result.
The vaccine manufacturers have, of course, not backed the move but then they are businesses who must protect their backs against litigation. What else do we expect from them.
Typically, BBC Scotland offer no balance in the form of a statement from a Chief Medical Officer. Here are the key points from the Scottish CMO in his statement on the 1st January 2021:
7. Following a review of the clinical evidence in relation to both the AstraZeneca and Pfizer BioNTech vaccines, the JCVI has recommended that first doses of vaccine are prioritised for as many people as possible on the Phase 1 JCVI priority list, in advance of second doses to provide more assured longer term protection.
8. This reflects the need to reach as many people in the shortest possible timeframe, within the available vaccine supplies, against a background of immediate disease activity and high population sero-susceptibility (despite the disease burden seen).
9. This is on the basis that the protection of vaccinees after the first in a two-dose schedule is very substantial. This evidence will be published by the JCVI and PHE.
10. This strategy is also strongly supported by the UK Chief Medical Officers and their Deputies.
You can see the full statement here: